Showing results (2261-2270 of 2,343) with videos related to
Sort By:
Pageof 235
Journal of the National Cancer Institute|September 17, 2016
Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2Stephen B Keysar, Phuong N Le, Bettina Miller, et al.American Journal of Respiratory and Critical Care Medicine|June 5, 2019
Understanding and Enhancing Sepsis Survivorship. Priorities for Research and PracticeHallie C Prescott, Theodore J Iwashyna, Bronagh Blackwood, et al.Plos Pathogens|October 7, 2022
Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaquesBrendon Y Chua, Toshiki Sekiya, Marios Koutsakos, et al.ESMO Gastrointestinal Oncology|February 6, 2026
ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trialJ Lee, A Dean, T Price, et al.Lancet (London, England)|January 15, 2008
Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trialTimothy D Girard, John P Kress, Barry D Fuchs, et al.International Journal of Radiation Oncology, Biology, Physics|April 9, 2019
Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective StudiesWilliam C Jackson, Jessica Silva, Holly E Hartman, et al.International Journal of Radiation Oncology, Biology, Physics|December 19, 2021
An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate CancerSoumyajit Roy, Nicholas G Zaorsky, Hilary P Bagshaw, et al.Journal for Immunotherapy of Cancer|May 3, 2023
BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphomaSharmila Raghunandan, Melinda Pauly, William G Blum, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-UpThomas Martin, Saad Z Usmani, Jesus G Berdeja, et al.Neurology|December 25, 2016
Refractory status epilepticus in children with and without prior epilepsy or status epilepticusIván Sánchez Fernández, Michele C Jackson, Nicholas S Abend, et al.Pageof 235